These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26189046)

  • 21. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
    Fed Regist; 1994 Jun; 59(116):31138. PubMed ID: 10136908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Faster approval for breakthrough devices.
    Ratner M
    Nat Biotechnol; 2014 Jul; 32(7):608. PubMed ID: 25004218
    [No Abstract]   [Full Text] [Related]  

  • 23. Industry perspective on FDA regulation of medical devices and the practice of medicine.
    Tandy MK
    Ann Thorac Surg; 1996 Jan; 61(1):485-6; discussion 493-8. PubMed ID: 8561635
    [No Abstract]   [Full Text] [Related]  

  • 24. Memorandum of understanding between the Food and Drug Administration and the Defense Alliance for Advanced Medical Terminology--FDA. Notice.
    Fed Regist; 1998 Jul; 63(129):36700-6. PubMed ID: 10181056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replacement parts. How the FDA allows faulty, and sometimes dangerous, medical devices onto the market.
    Roane KR
    US News World Rep; 2002 Jul; 133(4):54-9. PubMed ID: 12152351
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA's new regulatory paradigms for in vitro diagnostic devices.
    Robinowitz M; Gutman SI
    Cytotherapy; 1999; 1(4):353-7. PubMed ID: 20426566
    [No Abstract]   [Full Text] [Related]  

  • 27. U.S. Food and Drug Administration and regulation of medical devices in radiology.
    Pritchard WF; Carey RF
    Radiology; 1997 Oct; 205(1):27-36. PubMed ID: 9314955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiological Medical Device Innovation: Approvals via the Premarket Approval Pathway From 2000 to 2015.
    Ghobadi CW; Hayman EL; Finkle JH; Walter JR; Xu S
    J Am Coll Radiol; 2017 Jan; 14(1):24-33. PubMed ID: 28061962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How do regulatory agencies ensure the release of a safe medical device?
    Haggar B
    Clin Perform Qual Health Care; 1999; 7(2):100-3. PubMed ID: 10747561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change, but not in dollar bills. FDA needs more than money to fix problems: Congress.
    Lubell J
    Mod Healthc; 2008 Feb; 38(5):10-1. PubMed ID: 18320666
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; correction--FDA. Proposed rule; correction.
    Fed Regist; 1998 Nov; 63(228):65566. PubMed ID: 10338876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of medical devices in the United States and European Union.
    Kramer DB; Xu S; Kesselheim AS
    N Engl J Med; 2012 Mar; 366(9):848-55. PubMed ID: 22332952
    [No Abstract]   [Full Text] [Related]  

  • 34. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
    Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When informed consent is not required in studies.
    Maloney DM
    Hum Res Rep; 2006 Jun; 21(6):3. PubMed ID: 17111532
    [No Abstract]   [Full Text] [Related]  

  • 36. Medical devices; investigational device exemptions--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(225):64617-26. PubMed ID: 10338870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDA regulation of invasive neural recording electrodes: a daunting task for medical innovators.
    Welle C; Krauthamer V
    IEEE Pulse; 2012 Mar; 3(2):37-41. PubMed ID: 22481744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical devices; implementation of third party review under the Food and Drug Administration Modernization Act of 1997; emergency processing request under OMB review--FDA. Notice.
    Fed Regist; 1998 May; 63(99):28388-91. PubMed ID: 10179874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Of specialty interest: the Food and Drug Administration: a partner in safe practice.
    Baker K
    ORL Head Neck Nurs; 2003; 21(2):25-7. PubMed ID: 12747041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.